XXXX and Ki-67 expression as prognostic factors in @entity13392 .

@entity1 @entity5 @entity876 @entity3 @entity13392
We have reviewed the histopathological, clinical outcome and immunohistochemical status in 21 @entity1 with @entity13392 ( @entity13392 ) @entity5 of the breast. We assessed 12 @entity5 as histopathologically benign and 9 @entity5 as malignant. The median @entity1 ages in benign and @entity5 were 39.6 and 45.4 years of age, respectively. The stromal cellularity, stromal cellular atypism, high mitotic activity, atypic mitoses, stromal overgrowth, infiltrative @entity5 contour, and heterologous stromal elements were significant features of the @entity5 . @entity5 were predominantly of fibroadenomatous architecture with cellular stroma (mild or moderate) and some distortion and elongation of glandular elements. Five @entity5 were stained positively with @entity876 , and 6 @entity5 were stained immunohistochemically with Ki-67. All @entity5 were negatively stained for @entity876 and Ki-67. The @entity1 with @entity5 were treated with local excision ( n=11) and with subcutaneous mastectomy ( n=1). @entity5 were treated with wide local excision ( n=1), partial mastectomy ( n=1), simple mastectomy ( n=2), and modified radical mastectomy ( n=5). Two @entity1 with a high mitotic rate and high values of @entity876 and Ki-67 received additional radiotherapy and chemotherapy. One case had liver @entity3 . This @entity5 had high mitotic figures, stromal overgrowth, severe stromal cellularity, and 20% Ki-67 and mild @entity876 positivity. We suggest that @entity876 and Ki-67 can play an important role in predicting prognosis and yielding additional therapy besides conventional prognostic factors in the treatment of the @entity13392 @entity1 .
